genedrive (LON:GDR) Trading Down 4.4% – Should You Sell?

genedrive plc (LON:GDR)’s stock price dropped 4.4% during trading on Tuesday . The stock traded as low as GBX 2.11 ($0.03) and last traded at GBX 2.15 ($0.03). Approximately 3,086,236 shares were traded during trading, an increase of 19% from the average daily volume of 2,585,487 shares. The stock had previously closed at GBX 2.25 ($0.03).

genedrive Trading Down 4.4 %

The firm has a fifty day moving average of GBX 2.26 and a 200-day moving average of GBX 2.50. The stock has a market capitalization of £11.68 million, a price-to-earnings ratio of -53.75 and a beta of -0.04. The company has a debt-to-equity ratio of 8.57, a quick ratio of 5.52 and a current ratio of 1.63.

Insider Transactions at genedrive

In related news, insider Ian David Gilham purchased 225,000 shares of the company’s stock in a transaction dated Friday, December 20th. The shares were acquired at an average cost of GBX 2 ($0.02) per share, for a total transaction of £4,500 ($5,493.83). Corporate insiders own 14.75% of the company’s stock.

About genedrive

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.